Literature DB >> 19680255

A novel classification for IgA nephropathy.

Ryohei Yamamoto1, Enyu Imai.   

Abstract

IgA nephropathy is a common glomerulonephritis. About 30% of patients develop end-stage kidney disease within 20 years. A strategy for predicting prognosis from biopsy-based pathological evaluation has not been well established because of lack of reproducibility and inappropriate categorization. The new Oxford classification of IgA nephropathy provides a histopathological grading system with reproducibility for prediction of renal prognosis of IgA nephropathy independent of the clinical features. The classification must be validated in the different cohorts.

Entities:  

Mesh:

Year:  2009        PMID: 19680255     DOI: 10.1038/ki.2009.206

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  8 in total

1.  Pathology: Oxford IgA nephropathy classification: valid for children?

Authors:  Ryohei Yamamoto; Yasuyuki Nagasawa
Journal:  Nat Rev Nephrol       Date:  2010-11       Impact factor: 28.314

2.  The use of the Oxford classification of IgA nephropathy to predict renal survival.

Authors:  Eric Alamartine; Catherine Sauron; Blandine Laurent; Aurore Sury; Aline Seffert; Christophe Mariat
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-01       Impact factor: 8.237

3.  Oxford classification of IgA nephropathy: Broadening the scope of the classification.

Authors:  Muhammed Mubarak
Journal:  J Nephropathol       Date:  2012-04-05

4.  Oxford-MEST classification in IgA nephropathy patients: A report from Iran.

Authors:  Hamid Nasri; Mojgan Mortazavi; Ali Ghorbani; Heshmatollah Shahbazian; Soleiman Kheiri; Azar Baradaran; Afsoon Emami-Naieni; Maryam Saffari; Saeed Mardani; Ali Momeni; Yahya Madihi; Milad Baradaran-Ghahfarokhi; Mahmoud Rafieian-Kopaie; Parin Hedayati; Shahzad Baradaran; Mohammadreza Ardalan; Shahram Sajjadieh; Naziheh Assarzadegan; Seyed Mohammad Ahmadi Soleimani; Mohamad Reza Tamadon
Journal:  J Nephropathol       Date:  2012-04-05

5.  A proton nuclear magnetic resonance-based metabonomics study of metabolic profiling in immunoglobulin a nephropathy.

Authors:  Weiguo Sui; Liping Li; Wenti Che; Zuo Guimai; Jiejing Chen; Wuxian Li; Yong Dai
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

6.  Role of immunosuppressive therapy and predictors of therapeutic effectiveness and renal outcome in IgA nephropathy with proteinuria.

Authors:  Yiping Ruan; Wenfang Chen; Zhibin Li; Xueqing Tang; Jianbo Li; Xueqing Yu; Qiongqiong Yang
Journal:  Arch Med Sci       Date:  2015-04-23       Impact factor: 3.318

7.  Histopathological and immune alterations in autopsied kidneys.

Authors:  Ufuk Usta; Ebru Tastekin; Erhan Isler; Ali K Kutlu; Fulya Oz Puyan
Journal:  Saudi Med J       Date:  2014-11       Impact factor: 1.484

8.  Significance of segmental glomerulosclerosis in IgA nephropathy: What is the evidence?

Authors:  Muhammed Mubarak; Hamid Nasri
Journal:  J Renal Inj Prev       Date:  2013-10-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.